We all know that Big Pharma tries its best to sell “safe and effective” drugs. From “mother’s little helper” to thalidomide to Oxycontin—most folks with their eyes open know enough to be skeptical about ads for the new wonder drug. But what is much less obvious is the targeted attacking of cheaper and potentially better treatment options—options that are not patentable blockbuster drugs, and which might eat into Big Pharma’s bottom line. Big Pharma is even more insidious than you thought. We need to be skeptical of negative news as well.